resources

Divis Laboratories Ltd.

NSE: DIVISLAB

BSE: 532488

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

8,597.00+27.0 (+0.32%)

21 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Divis Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	—	—
Conference Calls	—	—	—	—	—	—	—	—	—	26May 12Aug 17Aug 7Nov 14Nov	8Feb 20May 25May 14Aug 19Aug 6Nov 11Nov	10Feb 16Feb 25May 30May 8Aug 15Nov	7Feb 23May 12Aug 12Nov	14Feb 29May 6Aug
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Divis Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

AGM10 Aug 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Scrutinizer''s report on 36th AGM resolutions.
AGM10 Aug 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 36th AGM - submission of AGM proceedings, voting results and Scrutinizer''s report.
Newspaper Publication3 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30, 2026
Analyst / Investor Meet1 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Intimation of Q1FY27 earnings call audio recording.
Change in Management1 Aug 2026
Announcement under Regulation 30 (LODR)-Change in Management
As per enclosed letter.
Outcome of Board Meeting1 Aug 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On August 01, 2026.
Outcome of Board meeting held on August 01, 2026.
Change in Management31 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Management
Intimation of retirement of Senior Management Personnel as detailed in the enclosed letter.
Analyst / Investor Meet24 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of earnings conference call for Q1 FY27
Board Meeting20 Jul 2026
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Newspaper Publication17 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Clippings - Notice of 36th AGM, e-voting & other information
AGM15 Jul 2026
Notice Of 36Th Annual General Meeting To Be Held On August 10, 2026
Intimation of notice of 36th AGM to be held on August 10, 2026.
Business Responsibility and Sustainability Reporting (BRSR)15 Jul 2026
Business Responsibility and Sustainability Reporting (BRSR)
Submission of BRSR report for the FY 2025-26.
Reg. 34 (1) Annual Report15 Jul 2026
Reg. 34 (1) Annual Report.
Notice of 36th Annual General Meeting and Annual Report for the financial year 2025-26.
Newspaper Publication13 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice regarding 36th Annual General Meeting, Record Date for dividend and other information
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026
Closure of Trading Window30 Jun 2026
Closure of Trading Window
Intimation of closure of Trading Window from July 01, 2026.
General11 Jun 2026
Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26
As per enclosed letter.
Newspaper Publication4 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF
Newspaper Publication25 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publications regarding audited financial results of the Company for the quarter and year ended March 31, 2026
Analyst / Investor Meet23 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Q4 FY26 earnings conference call held on May 23, 2026.

Frequently Asked Questions

Where can I download the annual report of Divis Laboratories Ltd.?

Annual reports of Divis Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Divis Laboratories Ltd.?

Quarterly earnings results and presentations of Divis Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Divis Laboratories Ltd. publish earnings call transcripts?

Earnings call transcripts of Divis Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Divis Laboratories Ltd.?

Investor presentations and annual day presentations of Divis Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Divis Laboratories Ltd.?

Corporate announcements and regulatory filings of Divis Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Divis Laboratories Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Divis Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Divis Laboratories Ltd.?

The ISIN (International Securities Identification Number) of Divis Laboratories Ltd. is INE361B01024. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Divis Laboratories Ltd. listed?

Divis Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is DIVISLAB and the BSE code is -.

Where can I find the shareholding pattern of Divis Laboratories Ltd.?

The quarterly shareholding pattern of Divis Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Divis Laboratories Ltd. on Sharpely?

Share price data for Divis Laboratories Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.